2005
DOI: 10.1016/j.clinbiochem.2005.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet–leukocyte aggregate formation occur simultaneously in hyperlipidemia?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
28
1
5

Year Published

2009
2009
2019
2019

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 44 publications
(38 citation statements)
references
References 37 publications
4
28
1
5
Order By: Relevance
“…Lipid peroxidation of membranes induced by reactive oxygen species alters the structure and function of membrane components followed by the platelet signaling pathway activation. Additionally, although platelets are anucleated cells, apoptosis like events take place both in vivo and in vitro and they can also synthesize proteins by using several transport mechanisms and the amino acids contents in their cytoplasms (7,8,9). PS (phosphatidylserine) exposure is recognized as a marker of cell death as well as being an activation marker.…”
Section: Introductionmentioning
confidence: 99%
“…Lipid peroxidation of membranes induced by reactive oxygen species alters the structure and function of membrane components followed by the platelet signaling pathway activation. Additionally, although platelets are anucleated cells, apoptosis like events take place both in vivo and in vitro and they can also synthesize proteins by using several transport mechanisms and the amino acids contents in their cytoplasms (7,8,9). PS (phosphatidylserine) exposure is recognized as a marker of cell death as well as being an activation marker.…”
Section: Introductionmentioning
confidence: 99%
“…Platelets from hypercholesterolemic humans have increased cholesterol content and hypersensitivity to endogenous aggregating agonists [9,21,25]. In familial hypercholesterolemic patients, cholesterol-lowering treatment with statin, an HMG-CoA reductase inhibitor, decreases the platelet cholesterol content and platelet sensitivity to the aggregating agonists such as ADP and collagen [9,17,18].…”
mentioning
confidence: 99%
“…Çekirdekli hücrelerde PS'in hücre zarı dış yüzeyine hareketi tam olarak bir apoptoz belirteci iken trombositlerde apoptozdan ziyade aktivasyonu düşündürmektedir. Trombosit aktivasyonu ve apoptozu benzer özellikler gösterirler (PS translokasyonu, mikropartikül oluşumu gibi) ki bu durum trombosit aktivasyonunun apoptoza ilerlediğini düşündür-mektedir (28,29). Ancak, trombosit apoptozunun ve aktivasyonunun birbirinden farklı ilerleyebileceğini gösteren çalış-malar da mevcuttur (30).…”
Section: Discussionunclassified